

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T cell migration (GO:0072678) | 7.44099680 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.55393133 |
| 3 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.38600254 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.27745765 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.79742313 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.77091660 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.77091660 |
| 8 | negative T cell selection (GO:0043383) | 5.49839938 |
| 9 | lymphocyte chemotaxis (GO:0048247) | 5.09499577 |
| 10 | positive thymic T cell selection (GO:0045059) | 5.05672997 |
| 11 | positive T cell selection (GO:0043368) | 4.99768615 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.90947288 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.77569138 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.76604907 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 4.69064156 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.67523617 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67100916 |
| 18 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.45149351 |
| 19 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.45149351 |
| 20 | response to interleukin-15 (GO:0070672) | 4.42531889 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.41931796 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 4.41504889 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.41287923 |
| 24 | T cell selection (GO:0045058) | 4.39516301 |
| 25 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.37121486 |
| 26 | thymic T cell selection (GO:0045061) | 4.36734561 |
| 27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.31422055 |
| 28 | lymphocyte migration (GO:0072676) | 4.31312534 |
| 29 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.26125760 |
| 30 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.23644793 |
| 31 | leukocyte aggregation (GO:0070486) | 4.21597033 |
| 32 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.19470617 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 4.15364741 |
| 34 | activated T cell proliferation (GO:0050798) | 4.10337484 |
| 35 | cytidine catabolic process (GO:0006216) | 4.05820253 |
| 36 | cytidine deamination (GO:0009972) | 4.05820253 |
| 37 | cytidine metabolic process (GO:0046087) | 4.05820253 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.05338938 |
| 39 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.04459172 |
| 40 | interferon-gamma production (GO:0032609) | 4.04097700 |
| 41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.94270359 |
| 42 | regulation of B cell differentiation (GO:0045577) | 3.92367615 |
| 43 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.89467657 |
| 44 | regulation of tolerance induction (GO:0002643) | 3.89137551 |
| 45 | regulation of defense response to virus by virus (GO:0050690) | 3.84842883 |
| 46 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.82228292 |
| 47 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.77072718 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.76367825 |
| 49 | positive regulation of tolerance induction (GO:0002645) | 3.75506603 |
| 50 | T cell receptor signaling pathway (GO:0050852) | 3.74953363 |
| 51 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.73145658 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.72147549 |
| 53 | detection of other organism (GO:0098543) | 3.67007669 |
| 54 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.62716253 |
| 55 | actin nucleation (GO:0045010) | 3.62544802 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 3.62003537 |
| 57 | positive regulation of lymphocyte migration (GO:2000403) | 3.61091489 |
| 58 | chemokine-mediated signaling pathway (GO:0070098) | 3.59982506 |
| 59 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.59625986 |
| 60 | detection of bacterium (GO:0016045) | 3.57889395 |
| 61 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.57196929 |
| 62 | respiratory burst (GO:0045730) | 3.54710572 |
| 63 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.53515496 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 3.53316894 |
| 65 | negative regulation of T cell mediated immunity (GO:0002710) | 3.50144637 |
| 66 | B cell mediated immunity (GO:0019724) | 3.46236248 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45613341 |
| 68 | positive regulation of cell killing (GO:0031343) | 3.45219076 |
| 69 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.44344022 |
| 70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.43727629 |
| 71 | cellular defense response (GO:0006968) | 3.42295518 |
| 72 | regulation of calcium-mediated signaling (GO:0050848) | 3.42104248 |
| 73 | regulation of cell killing (GO:0031341) | 3.39943913 |
| 74 | cellular extravasation (GO:0045123) | 3.37391447 |
| 75 | DNA deamination (GO:0045006) | 3.37080511 |
| 76 | T cell costimulation (GO:0031295) | 3.33295196 |
| 77 | eosinophil chemotaxis (GO:0048245) | 3.31620899 |
| 78 | T cell mediated immunity (GO:0002456) | 3.31598395 |
| 79 | positive regulation of T cell chemotaxis (GO:0010820) | 3.31114030 |
| 80 | regulation of T cell chemotaxis (GO:0010819) | 3.31114030 |
| 81 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.29318778 |
| 82 | lymphocyte costimulation (GO:0031294) | 3.28938190 |
| 83 | regulation of lymphocyte migration (GO:2000401) | 3.28236852 |
| 84 | neutrophil activation involved in immune response (GO:0002283) | 3.24338594 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23551340 |
| 86 | mast cell activation (GO:0045576) | 3.22634123 |
| 87 | dendritic cell chemotaxis (GO:0002407) | 3.19183139 |
| 88 | granulocyte activation (GO:0036230) | 3.17594025 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 3.17405895 |
| 90 | positive regulation of interleukin-2 production (GO:0032743) | 3.14081839 |
| 91 | neutrophil activation (GO:0042119) | 3.11931291 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 3.11750248 |
| 93 | regulation of activation of Janus kinase activity (GO:0010533) | 3.11565023 |
| 94 | cellular response to type I interferon (GO:0071357) | 3.09100898 |
| 95 | type I interferon signaling pathway (GO:0060337) | 3.09100898 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.08148552 |
| 97 | response to type I interferon (GO:0034340) | 3.07945321 |
| 98 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.06741563 |
| 99 | regulation of regulatory T cell differentiation (GO:0045589) | 3.06406794 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04556810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.55966632 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.91646800 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.80976778 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.09385782 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.36025853 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.99725566 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.59170075 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.52652660 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.44295719 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14957860 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.11580259 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98532010 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.78818551 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.76739284 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74244273 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67405469 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.66813276 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50661585 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.40520526 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.40114455 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.37379070 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.35824799 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.33458580 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32777490 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.28488827 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26520502 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98759202 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97045564 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90178016 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83826709 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83672275 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83657469 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.82083078 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81431554 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79329434 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79243880 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78723303 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.77483214 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56107799 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54846604 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53130865 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51812215 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50939302 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49319644 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.48391847 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39191124 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37442844 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.30908602 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30598252 |
| 50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24178278 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22658016 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20954884 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18914288 |
| 54 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18117806 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16767627 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13495442 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11194315 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07963204 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04174459 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03345299 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01660059 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00307077 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99319648 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98368173 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96323504 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96049718 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95833801 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94686467 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93440657 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93255852 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92925323 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90964204 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89992653 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88961164 |
| 75 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88445795 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83020035 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82735606 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82510635 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82063710 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81352293 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77573936 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.74537499 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74429247 |
| 84 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74127386 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73906513 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73716701 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73290771 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73103805 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72235488 |
| 90 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71715073 |
| 91 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.71635704 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71083569 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70106835 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70036990 |
| 95 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68447267 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.67796611 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65132009 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.63899500 |
| 99 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.63112259 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.62645693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.91207696 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.12813496 |
| 3 | MP0009785_altered_susceptibility_to | 3.93732095 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.54464101 |
| 5 | MP0006082_CNS_inflammation | 3.47970838 |
| 6 | MP0003724_increased_susceptibility_to | 3.33837710 |
| 7 | MP0005025_abnormal_response_to | 3.15517272 |
| 8 | MP0001800_abnormal_humoral_immune | 3.14897099 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.14209142 |
| 10 | MP0003436_decreased_susceptibility_to | 3.12341518 |
| 11 | MP0005387_immune_system_phenotype | 2.92386662 |
| 12 | MP0001790_abnormal_immune_system | 2.92386662 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.83366482 |
| 14 | MP0002723_abnormal_immune_serum | 2.82586815 |
| 15 | MP0001819_abnormal_immune_cell | 2.77975917 |
| 16 | MP0002419_abnormal_innate_immunity | 2.76397346 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.74765684 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.66413121 |
| 19 | MP0000685_abnormal_immune_system | 2.62899530 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.43093587 |
| 21 | MP0002405_respiratory_system_inflammati | 2.29560652 |
| 22 | MP0003045_fibrosis | 2.25513002 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.23606163 |
| 24 | MP0003866_abnormal_defecation | 2.16124090 |
| 25 | MP0002398_abnormal_bone_marrow | 2.12475204 |
| 26 | MP0000716_abnormal_immune_system | 2.08935893 |
| 27 | MP0003448_altered_tumor_morphology | 1.96552121 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.89484185 |
| 29 | MP0003303_peritoneal_inflammation | 1.87972587 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.87788335 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.86479865 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.79619397 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.76254632 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.76075194 |
| 35 | MP0002722_abnormal_immune_system | 1.73109036 |
| 36 | MP0002006_tumorigenesis | 1.66358703 |
| 37 | MP0002429_abnormal_blood_cell | 1.59569533 |
| 38 | MP0004947_skin_inflammation | 1.57689817 |
| 39 | MP0004381_abnormal_hair_follicle | 1.57509814 |
| 40 | MP0008469_abnormal_protein_level | 1.56575853 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.55260335 |
| 42 | MP0003690_abnormal_glial_cell | 1.54643529 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.47805180 |
| 44 | MP0005166_decreased_susceptibility_to | 1.44265911 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.44164806 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.42590204 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.37009265 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.36082889 |
| 49 | MP0002132_abnormal_respiratory_system | 1.30956731 |
| 50 | MP0000858_altered_metastatic_potential | 1.28553110 |
| 51 | MP0005310_abnormal_salivary_gland | 1.27802531 |
| 52 | MP0004883_abnormal_blood_vessel | 1.22561711 |
| 53 | MP0009763_increased_sensitivity_to | 1.13038260 |
| 54 | MP0000604_amyloidosis | 1.09610772 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.09412815 |
| 56 | MP0000343_altered_response_to | 1.00864495 |
| 57 | MP0001851_eye_inflammation | 0.96131817 |
| 58 | MP0001853_heart_inflammation | 0.91482328 |
| 59 | MP0008260_abnormal_autophagy | 0.87799922 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 0.86795794 |
| 61 | MP0009764_decreased_sensitivity_to | 0.85664342 |
| 62 | MP0002009_preneoplasia | 0.84456605 |
| 63 | MP0000920_abnormal_myelination | 0.84171435 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 0.82870457 |
| 65 | MP0002168_other_aberrant_phenotype | 0.80946274 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 0.80316809 |
| 67 | MP0005164_abnormal_response_to | 0.78279817 |
| 68 | MP0003828_pulmonary_edema | 0.75836505 |
| 69 | MP0003075_altered_response_to | 0.74884892 |
| 70 | MP0002396_abnormal_hematopoietic_system | 0.74258331 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.72518570 |
| 72 | MP0002019_abnormal_tumor_incidence | 0.71103385 |
| 73 | MP0002933_joint_inflammation | 0.67077683 |
| 74 | MP0003795_abnormal_bone_structure | 0.65933722 |
| 75 | MP0002693_abnormal_pancreas_physiology | 0.63879141 |
| 76 | MP0001542_abnormal_bone_strength | 0.61825995 |
| 77 | MP0005390_skeleton_phenotype | 0.60028975 |
| 78 | MP0004130_abnormal_muscle_cell | 0.59382683 |
| 79 | MP0006054_spinal_hemorrhage | 0.59220703 |
| 80 | MP0008873_increased_physiological_sensi | 0.57825685 |
| 81 | MP0001873_stomach_inflammation | 0.57396536 |
| 82 | MP0000490_abnormal_crypts_of | 0.57271399 |
| 83 | MP0009643_abnormal_urine_homeostasis | 0.56891240 |
| 84 | MP0003011_delayed_dark_adaptation | 0.55826611 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.53126556 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.52869950 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.51430396 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.51004497 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.49623185 |
| 90 | MP0000249_abnormal_blood_vessel | 0.47353546 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.47208849 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 0.45742194 |
| 93 | MP0002102_abnormal_ear_morphology | 0.45634917 |
| 94 | MP0001919_abnormal_reproductive_system | 0.43887311 |
| 95 | MP0002163_abnormal_gland_morphology | 0.41928779 |
| 96 | MP0003329_amyloid_beta_deposits | 0.41456529 |
| 97 | MP0009840_abnormal_foam_cell | 0.40433280 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.40341834 |
| 99 | MP0005451_abnormal_body_composition | 0.39953432 |
| 100 | MP0001663_abnormal_digestive_system | 0.39638569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.13874184 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.50944775 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.41654041 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.06158570 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.94971873 |
| 6 | Myositis (HP:0100614) | 4.64639776 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.63774911 |
| 8 | Stomatitis (HP:0010280) | 4.59571740 |
| 9 | Abnormality of T cells (HP:0002843) | 4.59437766 |
| 10 | Increased IgM level (HP:0003496) | 4.54920852 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.35959128 |
| 12 | Encephalitis (HP:0002383) | 4.32098362 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.13811621 |
| 14 | Optic neuritis (HP:0100653) | 4.13811621 |
| 15 | Orchitis (HP:0100796) | 4.05760153 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.04032359 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 4.04032359 |
| 18 | IgG deficiency (HP:0004315) | 3.94312316 |
| 19 | Meningitis (HP:0001287) | 3.92593585 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.90401143 |
| 21 | Recurrent skin infections (HP:0001581) | 3.86408905 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.78843406 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.75986183 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 3.74793737 |
| 25 | Recurrent viral infections (HP:0004429) | 3.69019908 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.57027334 |
| 27 | Aplastic anemia (HP:0001915) | 3.53816513 |
| 28 | Severe combined immunodeficiency (HP:0004430) | 3.50245276 |
| 29 | Pustule (HP:0200039) | 3.44456206 |
| 30 | Obstructive lung disease (HP:0006536) | 3.36848299 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.36848299 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28402947 |
| 33 | Hypoproteinemia (HP:0003075) | 3.27481975 |
| 34 | Recurrent bronchitis (HP:0002837) | 3.25471319 |
| 35 | Leukocytosis (HP:0001974) | 3.20722408 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.16762238 |
| 37 | Chronic diarrhea (HP:0002028) | 3.16370503 |
| 38 | Vasculitis (HP:0002633) | 3.15612403 |
| 39 | Pulmonary infiltrates (HP:0002113) | 3.15094036 |
| 40 | IgM deficiency (HP:0002850) | 3.11147166 |
| 41 | Acute hepatic failure (HP:0006554) | 3.03414149 |
| 42 | Combined immunodeficiency (HP:0005387) | 3.01447682 |
| 43 | Abnormality of eosinophils (HP:0001879) | 3.00162276 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 2.96664649 |
| 45 | Chest pain (HP:0100749) | 2.93623715 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.90448576 |
| 47 | Eosinophilia (HP:0001880) | 2.82464545 |
| 48 | Lymphopenia (HP:0001888) | 2.77752096 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.76998588 |
| 50 | Hemoptysis (HP:0002105) | 2.73126393 |
| 51 | Keratoconjunctivitis (HP:0001096) | 2.70222200 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.64029366 |
| 53 | Abnormality of the prostate (HP:0008775) | 2.62424811 |
| 54 | Granulocytopenia (HP:0001913) | 2.61788423 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61119855 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61119855 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61119855 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.61052212 |
| 59 | Arterial thrombosis (HP:0004420) | 2.60766075 |
| 60 | Thyroiditis (HP:0100646) | 2.55954366 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.55524520 |
| 62 | Urticaria (HP:0001025) | 2.54771343 |
| 63 | Anorexia (HP:0002039) | 2.54766012 |
| 64 | Gingival bleeding (HP:0000225) | 2.52399553 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.52186204 |
| 66 | Gingivitis (HP:0000230) | 2.49368862 |
| 67 | Pulmonary embolism (HP:0002204) | 2.47859385 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.45849071 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.42072015 |
| 70 | Broad face (HP:0000283) | 2.41783648 |
| 71 | Increased IgE level (HP:0003212) | 2.41687146 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.41513848 |
| 73 | Gangrene (HP:0100758) | 2.41257866 |
| 74 | Joint swelling (HP:0001386) | 2.39846840 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.39370994 |
| 76 | Epistaxis (HP:0000421) | 2.35174328 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.26078311 |
| 78 | Lymphoma (HP:0002665) | 2.23816261 |
| 79 | Petechiae (HP:0000967) | 2.22507788 |
| 80 | Colitis (HP:0002583) | 2.15687686 |
| 81 | Abnormality of B cell number (HP:0010975) | 2.06585738 |
| 82 | Hemiplegia (HP:0002301) | 2.06387212 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.04300655 |
| 84 | Polyneuropathy (HP:0001271) | 2.01850546 |
| 85 | Amaurosis fugax (HP:0100576) | 2.01244709 |
| 86 | Bronchitis (HP:0012387) | 2.00800492 |
| 87 | Glomerulopathy (HP:0100820) | 2.00436406 |
| 88 | Progressive neurologic deterioration (HP:0002344) | 1.91337445 |
| 89 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90295513 |
| 90 | Hypochromic microcytic anemia (HP:0004840) | 1.90138110 |
| 91 | Increased serum ferritin (HP:0003281) | 1.89006127 |
| 92 | Prolonged bleeding time (HP:0003010) | 1.87605961 |
| 93 | B lymphocytopenia (HP:0010976) | 1.84937131 |
| 94 | Prostate neoplasm (HP:0100787) | 1.84674513 |
| 95 | Nasal polyposis (HP:0100582) | 1.83241563 |
| 96 | Acne (HP:0001061) | 1.81401298 |
| 97 | Purpura (HP:0000979) | 1.80329319 |
| 98 | Episodic fever (HP:0001954) | 1.79808347 |
| 99 | Skin ulcer (HP:0200042) | 1.78046752 |
| 100 | Hypochromic anemia (HP:0001931) | 1.77905924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.67977508 |
| 2 | TXK | 3.54054764 |
| 3 | KDR | 3.47721082 |
| 4 | RIPK4 | 3.41603302 |
| 5 | BLK | 3.33276861 |
| 6 | GRK7 | 3.01363889 |
| 7 | FES | 2.80246283 |
| 8 | CSK | 2.75978734 |
| 9 | TESK2 | 2.75961530 |
| 10 | TAOK3 | 2.65186115 |
| 11 | STK10 | 2.36747562 |
| 12 | TYK2 | 2.28056216 |
| 13 | BTK | 2.20652853 |
| 14 | ITK | 2.18671832 |
| 15 | TGFBR2 | 2.12001481 |
| 16 | ZAP70 | 2.05427433 |
| 17 | JAK3 | 1.99724348 |
| 18 | SYK | 1.94749034 |
| 19 | GRK6 | 1.91089850 |
| 20 | ERN1 | 1.88518136 |
| 21 | TEC | 1.72167699 |
| 22 | LCK | 1.70218597 |
| 23 | JAK1 | 1.60353310 |
| 24 | MAP3K11 | 1.58841715 |
| 25 | MOS | 1.57252992 |
| 26 | HCK | 1.57133120 |
| 27 | PRKCQ | 1.50168822 |
| 28 | MAP2K3 | 1.49522373 |
| 29 | LYN | 1.40770621 |
| 30 | TNK2 | 1.37055029 |
| 31 | IKBKE | 1.36424428 |
| 32 | MAP3K12 | 1.32734989 |
| 33 | TBK1 | 1.27037517 |
| 34 | IRAK4 | 1.24909273 |
| 35 | MAP3K14 | 1.20516471 |
| 36 | JAK2 | 1.18554362 |
| 37 | MAP3K3 | 1.16559702 |
| 38 | CSF1R | 1.14638231 |
| 39 | ADRBK2 | 1.14559137 |
| 40 | FGR | 1.10072085 |
| 41 | SCYL2 | 1.00843816 |
| 42 | MAP3K13 | 0.97948087 |
| 43 | BMPR2 | 0.97856044 |
| 44 | MARK3 | 0.97517314 |
| 45 | MAP3K5 | 0.94864277 |
| 46 | CAMKK2 | 0.93316069 |
| 47 | MAPK11 | 0.93040132 |
| 48 | PDK1 | 0.92896595 |
| 49 | PRPF4B | 0.90992810 |
| 50 | KIT | 0.88838245 |
| 51 | EPHB1 | 0.88239106 |
| 52 | PIK3CG | 0.87045937 |
| 53 | SIK3 | 0.82271954 |
| 54 | TAF1 | 0.80180880 |
| 55 | TAOK1 | 0.79802870 |
| 56 | FYN | 0.75868680 |
| 57 | CDK4 | 0.72107842 |
| 58 | IKBKB | 0.71913657 |
| 59 | GRK5 | 0.66503258 |
| 60 | TESK1 | 0.66464975 |
| 61 | MAP3K1 | 0.66269775 |
| 62 | TYRO3 | 0.65168961 |
| 63 | PIM1 | 0.63103694 |
| 64 | TAOK2 | 0.61026202 |
| 65 | NEK6 | 0.60815836 |
| 66 | PRKCH | 0.60731440 |
| 67 | MAPKAPK2 | 0.60483922 |
| 68 | TRPM7 | 0.51375633 |
| 69 | FGFR3 | 0.49648212 |
| 70 | SIK2 | 0.49220608 |
| 71 | LRRK2 | 0.47136341 |
| 72 | CLK1 | 0.46269553 |
| 73 | YES1 | 0.45830820 |
| 74 | NLK | 0.45704039 |
| 75 | INSR | 0.44553181 |
| 76 | CDK6 | 0.43470837 |
| 77 | MATK | 0.41699371 |
| 78 | EIF2AK3 | 0.40073761 |
| 79 | CDC42BPA | 0.39896235 |
| 80 | MAP3K7 | 0.38602259 |
| 81 | IGF1R | 0.37127012 |
| 82 | FGFR4 | 0.35951356 |
| 83 | NEK9 | 0.35839930 |
| 84 | PTK6 | 0.33969919 |
| 85 | PDGFRB | 0.33216081 |
| 86 | MAPKAPK3 | 0.33133909 |
| 87 | PTK2B | 0.31435747 |
| 88 | HIPK2 | 0.31060395 |
| 89 | ADRBK1 | 0.28966303 |
| 90 | CAMKK1 | 0.27236121 |
| 91 | ABL1 | 0.27096064 |
| 92 | CDK3 | 0.26836258 |
| 93 | MELK | 0.26797092 |
| 94 | MAPK12 | 0.26511199 |
| 95 | IRAK1 | 0.21723954 |
| 96 | PDPK1 | 0.19826400 |
| 97 | EGFR | 0.19612907 |
| 98 | MAP2K6 | 0.18636107 |
| 99 | PRKCD | 0.18583718 |
| 100 | NTRK2 | 0.18472561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.67072788 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.64077090 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.54667969 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.11924862 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.08638323 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.05867218 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.93829605 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.72196909 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.47064953 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30175790 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28348328 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.23828799 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.13740707 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11958661 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10183728 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.98029628 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.97869280 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87531689 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.81675663 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.81506053 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.80692874 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68610987 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61365496 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59802765 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.55406149 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50448020 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45662531 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.45531086 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42162310 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33360561 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31633611 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25078348 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.23918729 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.22891567 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17682248 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16999599 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09258769 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.06339561 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06240589 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.04099425 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.02819700 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.01817379 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99917723 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96507872 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.92947171 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.90874900 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88095178 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.75361350 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72940910 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70246197 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69902832 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68507623 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68293294 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66154982 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64978650 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.63537640 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59060041 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.54490758 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.53903208 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53436815 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52505048 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49747626 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45045147 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44950740 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.43717319 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42513087 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42332368 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41192169 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40271342 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38460665 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38309992 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30876079 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30431041 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29090393 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26833607 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26646903 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26499408 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25474248 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25456968 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24941704 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23739815 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23317771 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22413926 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19820994 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17594510 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.16426557 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.15839882 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.13396653 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13047381 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.11408435 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11122731 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.10780945 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.10682597 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.10608855 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08141394 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07993448 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.07368920 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.07253768 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.07235511 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07051101 |

